Figure 5.
(A) In vitro cumulative permeation quantity of different formulations. (B) In vitro cumulative permeation quantity of SH from SH-G and SH-MN. (C) Effect of flow rate on in vitro recovery of microdialysis probes. (D) Effect of concentration on in vitro recovery of microdialysis probes. (E) Effect of flow rate on in vivo recovery of microdialysis probes. (F) Effect of concentration on in vivo recovery of microdialysis probes. (G) Concentration-time curves of SH in the skin and (H) blood (mean ± SD; n = 5).